Medline (MDLN) Total Non-Current Liabilities (2024 - 2026)

Medline (MDLN) has reported Total Non-Current Liabilities for 3 consecutive years, with $17.6 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Non-Current Liabilities changed N/A year-over-year to $17.6 billion in Q2 2026; TTM through Jun 2026 was $17.6 billion, a N/A change from a year earlier, with the FY2025 full-year figure at $16.7 billion, down 1.8% from the prior year.
• Total Non-Current Liabilities was $17.6 billion for Q2 2026 at Medline, up from $17.1 billion in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $17.6 billion in Q2 2026 and troughed at $16.7 billion in Q4 2025.
• A 3-year average of $17.1 billion and a median of $17.1 billion in 2024 frame the typical range for Total Non-Current Liabilities.
• The widest YoY moves for Total Non-Current Liabilities: up 1.8% in 2025, down 1.8% in 2025.
• Over 3 years, Total Non-Current Liabilities stood at $17.0 billion in 2024, then declined by 1.8% to $16.7 billion in 2025, then gained by 5.12% to $17.6 billion in 2026.
• The last three Total Non-Current Liabilities figures came in at $17.6 billion (Q2 2026), $17.1 billion (Q1 2026), and $16.7 billion (Q4 2025), per Business Quant data.